In this respect, the trace amine-associated receptor 1 (TAAR1) agonist ulotaront that is effective in schizophrenia (Correll et al., 2021) was shown to modulate striatal and hippocampal glutamate function in a state-dependent manner (Yang et al., 2023). Here, TAAR1 is linked to schizophrenia.